Nov 6, 2012 (Started Nov 06, 2012)

  • Effectiveness
    Major (for renal cell cancer)
  • Side effects
    Mild (for Overall) (uncomfortable)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: One time

  • 0 helpful marks